Alnate, a dual-action antiparasitic medication that pairs albendazole and ivermectin in a single tablet, is emerging in U.S. clinics and public-health discussions as a quiet yet powerful defender. It protects families, travelers, outdoor adventurers, and vulnerable populations from parasitic infections that often go unnoticed — infections traditionally thought of as distant problems but now recognized as real, if hidden, threats on American soil. As researchers and clinicians deepen their focus on overlooked diseases, Alnate represents both a scientific advancement and a cultural marker: a lens into how modern societies confront ancient biological foes. Shadows Beneath the Surface: Parasitic Disease in…